{"version":"1.0","type":"link","title":"A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving durvalumab in combination with tremelimumab.","author_name":"Cheng Y 외","author_url":"https://prs-insight.online/author/Cheng%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/117014","thumbnail_width":1200,"thumbnail_height":630}